CRI held its annual Awards Dinner on October 3, 2011, and 290 guests attended the festivities at 583 Park Avenue in New York City.
At the event, CRI honored several individuals whose work has helped to advance the science and clinical development of cancer immunotherapies, including: Mitchell Gold, M.D., President and CEO of Dendreon Corporation, who received the 2011 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research for his leadership in advancing the first FDA-approved therapeutic cancer vaccine; celebrated film and television producer Laura Ziskin, who was presented the 2011 Oliver R. Grace Award posthumously for her work to raise awareness and funds for cancer research through Stand Up To Cancer and her belief in the power of immunotherapy for cancer; Philip D. Greenberg, M.D., and Steven A. Rosenberg, M.D., Ph.D., who received the William B. Coley Award for Distinguished Research in Tumor Immunology for their pioneering work in adoptive immunotherapy; and Stephen C. Jameson, Ph.D., who received the Frederick W. Alt Award for New Discoveries in Immunology for his seminal contributions to our understanding of immune cell development and activation.
In presenting the Coley Award to Drs. Greenberg and Rosenberg, CRI Scientific Advisory Council director James P. Allison, Ph.D., recalled the announcement made earlier that day that three immunologists—Bruce Beutler, Jules Hoffmann, and Ralph Steinman—received the 2011 Nobel Prize in Physiology or Medicine, signaling not only that immunology is now widely recognized as central to efforts to combat disease, but also that CRI’s Coley Award is an indicator of future Nobel Prize winners: all three of this year’s Nobel laureates are past Coley Award winners, bringing the total of past Coley Award recipients who later won the Nobel to six. Many other Coley Award winners have won other major scientific prizes, including the Albert Lasker Award (often called the "American Nobel"), Canada Gairdner Award, Shaw Prize (the "Nobel of the East"), Albany Medical Center Prize, and Keio Prize.
The event raised $625,000 for CRI. The event also marked the launch of The WHITE Campaign, CRI’s campaign to increase awareness of the potential of immunotherapy to treat and cure all types of cancer, with attendees at the dinner wearing WHITE ribbons in support of CRI’s efforts to advance this new approach to cancer treatment. James P. Allison, Ph.D., John Fitzgibbons, Don Gogel, Ellen Puré, Ph.D., Paul Sekhri, Paul Shiverick, and Jim Wiatt served as event co-chairs and presenters. DeMarco Morgan, anchor/reporter for NBC4 New York, served as master of ceremonies.
Read the press release here.